Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
Status:
Completed
Trial end date:
2016-10-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety, and tolerability of vilazodone
relative to placebo in adolescent outpatients (12-17) with major depressive disorder.